Wells Fargo & Company Lowers UnitedHealth Group (NYSE:UNH) Price Target to $351.00

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price objective decreased by stock analysts at Wells Fargo & Company from $677.00 to $351.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an "overweight" rating on the healthcare conglomerate's stock. Wells Fargo & Company's price target suggests a potential upside of 10.59% from the stock's current price.

Other equities research analysts also recently issued research reports about the company. Barclays decreased their price target on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Truist Financial reduced their price objective on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research report on Monday, April 21st. KeyCorp cut their target price on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating on the stock in a research note on Wednesday. HSBC reissued a "hold" rating and issued a $490.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, April 22nd. Finally, Morgan Stanley dropped their price objective on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Six investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $545.57.

UnitedHealth Group Trading Up 1.9%

Shares of NYSE:UNH traded up $6.01 during midday trading on Wednesday, hitting $317.39. 10,862,572 shares of the stock were exchanged, compared to its average volume of 4,996,842. The business's 50-day moving average price is $482.53 and its 200 day moving average price is $519.28. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group has a 12 month low of $309.10 and a 12 month high of $630.73. The stock has a market capitalization of $287.91 billion, a price-to-earnings ratio of 20.43, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the company posted $6.91 EPS. Analysts predict that UnitedHealth Group will post 29.54 earnings per share for the current year.

Institutional Investors Weigh In On UnitedHealth Group

Large investors have recently made changes to their positions in the stock. Rosenberg Matthew Hamilton increased its stake in UnitedHealth Group by 50.3% during the 4th quarter. Rosenberg Matthew Hamilton now owns 1,320 shares of the healthcare conglomerate's stock worth $668,000 after buying an additional 442 shares during the period. Tuttle Capital Management LLC grew its stake in UnitedHealth Group by 34.1% during the 4th quarter. Tuttle Capital Management LLC now owns 629 shares of the healthcare conglomerate's stock worth $318,000 after purchasing an additional 160 shares in the last quarter. Tlwm raised its position in UnitedHealth Group by 4.0% in the 4th quarter. Tlwm now owns 2,708 shares of the healthcare conglomerate's stock valued at $1,370,000 after purchasing an additional 105 shares in the last quarter. Lpwm LLC increased its stake in shares of UnitedHealth Group by 80.8% during the fourth quarter. Lpwm LLC now owns 866 shares of the healthcare conglomerate's stock worth $438,000 after buying an additional 387 shares during the period. Finally, SeaCrest Wealth Management LLC grew its holdings in UnitedHealth Group by 2.3% during the 4th quarter. SeaCrest Wealth Management LLC now owns 3,223 shares of the healthcare conglomerate's stock worth $1,630,000 after acquiring an additional 71 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.